Reported Feb 15, 2017 · Terminated

Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada, M9L 1T9;…

Apotex Inc.

Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Apotex Inc. · 150 Signet Drive · Toronto, N/A · N/A

Is this the product you have?

  • Aripiprazole Tablets, 2 mg, 30-count bottle, Rx only
  • Manufactured byApotex Inc., Toronto, Ontario, Canada, M9L 1T9
  • Manufactured forApotex Corp., Weston, Florida 33326, NDC 60505-3075-3
Lot codes and dates
    • Lot #: MJ7746
    • Exp 04/17
Amount recalled
67,946 bottles

Where it was sold

  • Nationwide

Why it was recalled

Superpotent Drug: Product may not meet specifications throughout shelf life.

This product is unlikely to cause harm, but it breaks a safety or labelling rule.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Apotex Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Jun 15, 2022 · Data as of Sep 19, 5:01 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.